Exact Mass: 508.4280076

Exact Mass Matches: 508.4280076

Found 223 metabolites which its exact mass value is equals to given mass value 508.4280076, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DG(14:1(9Z)/14:1(9Z)/0:0)

(2S)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (9Z)-tetradec-9-enoate

C31H56O5 (508.41275260000003)


DG(14:1(9Z)/14:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:1(9Z)/14:1(9Z)/0:0), in particular, consists of two chains of myristoleic acid at the C-1 and C-2 positions. The myristoleic acid moieties are derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(14:1n5/0:0/14:1n5)

2-Hydroxy-3-[(5Z)-tetradec-5-enoyloxy]propyl (5Z)-tetradec-5-enoic acid

C31H56O5 (508.41275260000003)


DG(14:1n5/0:0/14:1n5) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1 C-2, or C-3 positions. DG(14:1n5/0:0/14:1n5), in particular, consists of two chains of myristoleic acid at the C-1 and C-3 positions. The myristoleic acid moieties are derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

FAHFA(16:1(9Z)/5-O-16:0)

5-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/5-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 5-hydroxyhexadecanoic acid. It is alternatively named 5-POHPA since it is the 5-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/7-O-16:0)

7-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/7-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 7-hydroxyhexadecanoic acid. It is alternatively named 7-POHPA since it is the 7-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/8-O-16:0)

8-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/8-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 8-hydroxyhexadecanoic acid. It is alternatively named 8-POHPA since it is the 8-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/9-O-16:0)

9-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/9-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 9-hydroxyhexadecanoic acid. It is alternatively named 9-POHPA since it is the 9-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/10-O-16:0)

10-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/10-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 10-hydroxyhexadecanoic acid. It is alternatively named 10-POHPA since it is the 10-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/11-O-16:0)

11-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/11-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 11-hydroxyhexadecanoic acid. It is alternatively named 11-POHPA since it is the 11-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/12-O-16:0)

12-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/12-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 12-hydroxyhexadecanoic acid. It is alternatively named 12-POHPA since it is the 12-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/13-O-16:0)

13-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/13-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 13-hydroxyhexadecanoic acid. It is alternatively named 13-POHPA since it is the 13-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/6-O-16:0)

6-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/6-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 6-hydroxyhexadecanoic acid. It is alternatively named 6-POHPA since it is the 6-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

Alexidine

1-{N-[6-(N-{amino[N-(2-ethylhexyl)carbamimidamido]methylidene}amino)hexyl]carbamimidamido}-N-(2-ethylhexyl)methanimidamide

C26H56N10 (508.46891760000005)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

2-[2-A-Neo-30-norgammaceran-22-yl]ethyl]thiophene

2-[2-A-Neo-30-norgammaceran-22-yl]ethyl]thiophene

C35H56S (508.41024960000004)


   
   
   

Tigloyl-10(30)-Taraxasten-3-ol

Tigloyl-10(30)-Taraxasten-3-ol

C35H56O2 (508.4280076)


   
   
   

Taraxasteroltiglinsaeureester|Tigloyl-20(30)-Taraxasten-3-ol

Taraxasteroltiglinsaeureester|Tigloyl-20(30)-Taraxasten-3-ol

C35H56O2 (508.4280076)


   
   
   

alexidine

alexidine

C26H56N10 (508.46891760000005)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

Diglyceride

1,2-dimyristoleoyl-rac-glycerol

C31H56O5 (508.41275260000003)


   

5-POHPA

5-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

7-POHPA

7-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

8-POHPA

8-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

9-POHPA

9-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

10-POHPA

10-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

11-POHPA

11-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

12-POHPA

12-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

13-POHPA

13-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

DG 28:2

1,2-di-(9Z-tetradecenoyl)-sn-glycerol

C31H56O5 (508.41275260000003)


   
   

ditetradecyl but-2-enedioate

ditetradecyl but-2-enedioate

C32H60O4 (508.449136)


   

1,4-Cyclohexanediylbis(methylene) didodecanoate

1,4-Cyclohexanediylbis(methylene) didodecanoate

C32H60O4 (508.449136)


   

Bis(1,2,2,6,6-pentamethyl-4-piperidinyl) sebacate

Bis(1,2,2,6,6-pentamethyl-4-piperidinyl) sebacate

C30H56N2O4 (508.42398560000004)


   
   

(4Z,8Z,12Z,16Z,20Z,24Z)-4,8,12,16,20,24-hexamethyl-28-oxononacosa-4,8,12,16,20,24-hexaenal

(4Z,8Z,12Z,16Z,20Z,24Z)-4,8,12,16,20,24-hexamethyl-28-oxononacosa-4,8,12,16,20,24-hexaenal

C35H56O2 (508.4280076)


   

[3-carboxy-2-[(13E,16E)-tetracosa-13,16-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(13E,16E)-tetracosa-13,16-dienoyl]oxypropyl]-trimethylazanium

C31H58NO4+ (508.43656080000005)


   

[3-Carboxy-2-[13-(3-methyl-5-pentylfuran-2-yl)tridecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[13-(3-methyl-5-pentylfuran-2-yl)tridecanoyloxy]propyl]-trimethylazanium

C30H54NO5+ (508.4001774)


   

[3-Carboxy-2-[11-(5-hexyl-3,4-dimethylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[11-(5-hexyl-3,4-dimethylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

C30H54NO5+ (508.4001774)


   

[3-Carboxy-2-[11-(5-heptyl-3-methylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[11-(5-heptyl-3-methylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

C30H54NO5+ (508.4001774)


   

[3-Carboxy-2-[12-(3,4-dimethyl-5-pentylfuran-2-yl)dodecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[12-(3,4-dimethyl-5-pentylfuran-2-yl)dodecanoyloxy]propyl]-trimethylazanium

C30H54NO5+ (508.4001774)


   

[3-carboxy-2-[(18Z,21E)-tetracosa-18,21-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(18Z,21E)-tetracosa-18,21-dienoyl]oxypropyl]-trimethylazanium

C31H58NO4+ (508.43656080000005)


   

2-Mohsa [dmed-fahfa]

2-Mohsa [dmed-fahfa]

C32H60O4 (508.449136)


   

[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

C31H56O5 (508.41275260000003)


   

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentanoate

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentanoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonanoate

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonanoate

C32H60O4 (508.449136)


   

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] propanoate

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] propanoate

C32H60O4 (508.449136)


   

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] heptanoate

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] heptanoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C32H60O4 (508.449136)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] octanoate

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] octanoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-nonoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-hydroxy-3-nonoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C32H60O4 (508.449136)


   

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C32H60O4 (508.449136)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C32H60O4 (508.449136)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] undecanoate

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] undecanoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-tridecoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-hydroxy-3-tridecoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C32H60O4 (508.449136)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

C32H60O4 (508.449136)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tridecanoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tridecanoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] decanoate

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] decanoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C32H60O4 (508.449136)


   
   
   
   

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-pentadec-9-enoate

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-pentadec-9-enoate

C35H56O2 (508.4280076)


   
   
   
   
   

Fahfa 21:1/11:0

Fahfa 21:1/11:0

C32H60O4 (508.449136)


   

Fahfa 11:0/21:1

Fahfa 11:0/21:1

C32H60O4 (508.449136)


   

Fahfa 15:1/17:0

Fahfa 15:1/17:0

C32H60O4 (508.449136)


   

Fahfa 13:0/19:1

Fahfa 13:0/19:1

C32H60O4 (508.449136)


   

Fahfa 16:0/16:1

Fahfa 16:0/16:1

C32H60O4 (508.449136)


   

Fahfa 18:0/14:1

Fahfa 18:0/14:1

C32H60O4 (508.449136)


   

Fahfa 13:1/19:0

Fahfa 13:1/19:0

C32H60O4 (508.449136)


   

Fahfa 14:0/18:1

Fahfa 14:0/18:1

C32H60O4 (508.449136)


   

Fahfa 17:1/15:0

Fahfa 17:1/15:0

C32H60O4 (508.449136)


   

Fahfa 10:0/22:1

Fahfa 10:0/22:1

C32H60O4 (508.449136)


   

Fahfa 22:1/10:0

Fahfa 22:1/10:0

C32H60O4 (508.449136)


   

Fahfa 12:0/20:1

Fahfa 12:0/20:1

C32H60O4 (508.449136)


   

Fahfa 17:0/15:1

Fahfa 17:0/15:1

C32H60O4 (508.449136)


   

Fahfa 20:1/12:0

Fahfa 20:1/12:0

C32H60O4 (508.449136)


   

Fahfa 19:0/13:1

Fahfa 19:0/13:1

C32H60O4 (508.449136)


   

Fahfa 15:0/17:1

Fahfa 15:0/17:1

C32H60O4 (508.449136)


   

Fahfa 19:1/13:0

Fahfa 19:1/13:0

C32H60O4 (508.449136)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

(1-decanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-decanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-pentadec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C31H56O5 (508.41275260000003)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C31H56O5 (508.41275260000003)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

(1-acetyloxy-3-hydroxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

C31H56O5 (508.41275260000003)


   

(1-heptanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

(1-heptanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C31H56O5 (508.41275260000003)


   

(1-hydroxy-3-octanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-hydroxy-3-octanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C31H56O5 (508.41275260000003)


   

(1-hexanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

(1-hexanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C31H56O5 (508.41275260000003)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,12E)-octadeca-9,12-dienoate

[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,12E)-octadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C31H56O5 (508.41275260000003)


   

[(2S)-3-hydroxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-tetradec-9-enoate

[(2S)-3-hydroxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-tetradec-9-enoate

C31H56O5 (508.41275260000003)


   

(2-dodecanoyloxy-3-hydroxypropyl) (4E,7E)-hexadeca-4,7-dienoate

(2-dodecanoyloxy-3-hydroxypropyl) (4E,7E)-hexadeca-4,7-dienoate

C31H56O5 (508.41275260000003)


   

1,2-Dimyristoleoyl-sn-glycerol

1,2-Dimyristoleoyl-sn-glycerol

C31H56O5 (508.41275260000003)


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are both myristoleoyl groups.

   

5-(9Z-hexadecenoyloxy)-hexadecanoic acid

5-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

diacylglycerol 28:2

diacylglycerol 28:2

C31H56O5 (508.41275260000003)


A diglyceride in which the two acyl groups contain a total of 28 carbons and 2 double bonds.

   

TG(28:2)

TG(16:2(1)_6:0_6:0)

C31H56O5 (508.41275260000003)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 10:0/O-22:1

FAHFA 10:0/O-22:1

C32H60O4 (508.449136)


   

FAHFA 10:1/O-22:0

FAHFA 10:1/O-22:0

C32H60O4 (508.449136)


   

FAHFA 11:0/O-21:1

FAHFA 11:0/O-21:1

C32H60O4 (508.449136)


   

FAHFA 11:1/O-21:0

FAHFA 11:1/O-21:0

C32H60O4 (508.449136)


   

FAHFA 12:0/O-20:1

FAHFA 12:0/O-20:1

C32H60O4 (508.449136)


   

FAHFA 12:1/O-20:0

FAHFA 12:1/O-20:0

C32H60O4 (508.449136)


   

FAHFA 13:0/O-19:1

FAHFA 13:0/O-19:1

C32H60O4 (508.449136)


   

FAHFA 13:1/O-19:0

FAHFA 13:1/O-19:0

C32H60O4 (508.449136)


   

FAHFA 14:0/O-18:1

FAHFA 14:0/O-18:1

C32H60O4 (508.449136)


   

FAHFA 14:1(9Z)/12O-18:0

FAHFA 14:1(9Z)/12O-18:0

C32H60O4 (508.449136)


   

FAHFA 14:1/O-18:0

FAHFA 14:1/O-18:0

C32H60O4 (508.449136)


   

FAHFA 15:0/O-17:1

FAHFA 15:0/O-17:1

C32H60O4 (508.449136)


   

FAHFA 15:1/O-17:0

FAHFA 15:1/O-17:0

C32H60O4 (508.449136)


   

FAHFA 16:0/O-16:1

FAHFA 16:0/O-16:1

C32H60O4 (508.449136)


   

FAHFA 16:1(9Z)/3O-16:0

FAHFA 16:1(9Z)/3O-16:0

C32H60O4 (508.449136)


   

FAHFA 16:1/O-16:0

FAHFA 16:1/O-16:0

C32H60O4 (508.449136)


   

FAHFA 17:0/O-15:1

FAHFA 17:0/O-15:1

C32H60O4 (508.449136)


   

FAHFA 17:1(9Z)/15O-15:0

FAHFA 17:1(9Z)/15O-15:0

C32H60O4 (508.449136)


   

FAHFA 17:1/O-15:0

FAHFA 17:1/O-15:0

C32H60O4 (508.449136)


   

FAHFA 18:0/O-14:1

FAHFA 18:0/O-14:1

C32H60O4 (508.449136)


   

FAHFA 18:1(9Z)/2O-14:0

FAHFA 18:1(9Z)/2O-14:0

C32H60O4 (508.449136)


   

FAHFA 18:1/O-14:0

FAHFA 18:1/O-14:0

C32H60O4 (508.449136)


   

FAHFA 19:0/O-13:1

FAHFA 19:0/O-13:1

C32H60O4 (508.449136)


   

FAHFA 19:1(10Z)/3O-13:0

FAHFA 19:1(10Z)/3O-13:0

C32H60O4 (508.449136)


   

FAHFA 19:1/O-13:0

FAHFA 19:1/O-13:0

C32H60O4 (508.449136)


   

FAHFA 20:0/O-12:1

FAHFA 20:0/O-12:1

C32H60O4 (508.449136)


   

FAHFA 20:1(11Z)/3O-12:0

FAHFA 20:1(11Z)/3O-12:0

C32H60O4 (508.449136)


   

FAHFA 20:1/O-12:0

FAHFA 20:1/O-12:0

C32H60O4 (508.449136)


   

FAHFA 21:0/O-11:1

FAHFA 21:0/O-11:1

C32H60O4 (508.449136)


   

FAHFA 21:1/O-11:0

FAHFA 21:1/O-11:0

C32H60O4 (508.449136)


   

FAHFA 22:0/O-10:1

FAHFA 22:0/O-10:1

C32H60O4 (508.449136)


   

FAHFA 22:1(13Z)/3O-10:0

FAHFA 22:1(13Z)/3O-10:0

C32H60O4 (508.449136)


   

FAHFA 22:1/O-10:0

FAHFA 22:1/O-10:0

C32H60O4 (508.449136)


   

FAHFA 23:0/O-9:1

FAHFA 23:0/O-9:1

C32H60O4 (508.449136)


   

FAHFA 23:1(14Z)/3O-9:0

FAHFA 23:1(14Z)/3O-9:0

C32H60O4 (508.449136)


   

FAHFA 23:1/O-9:0

FAHFA 23:1/O-9:0

C32H60O4 (508.449136)


   

FAHFA 24:0/O-8:1

FAHFA 24:0/O-8:1

C32H60O4 (508.449136)


   

FAHFA 24:1(15Z)/3O-8:0

FAHFA 24:1(15Z)/3O-8:0

C32H60O4 (508.449136)


   

FAHFA 24:1/O-8:0

FAHFA 24:1/O-8:0

C32H60O4 (508.449136)


   

FAHFA 8:0/O-24:1

FAHFA 8:0/O-24:1

C32H60O4 (508.449136)


   

FAHFA 8:1/O-24:0

FAHFA 8:1/O-24:0

C32H60O4 (508.449136)


   

FAHFA 9:0/O-23:1

FAHFA 9:0/O-23:1

C32H60O4 (508.449136)


   

FAHFA 9:1/O-23:0

FAHFA 9:1/O-23:0

C32H60O4 (508.449136)


   
   
   
   
   
   
   
   
   

(1r,3ar,5ar,6r,7r,9ar,9br,11ar)-1-[(2r,3e)-4-(1,3-dimethyl-5,6-dihydro-2h-pyridin-4-yl)but-3-en-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

(1r,3ar,5ar,6r,7r,9ar,9br,11ar)-1-[(2r,3e)-4-(1,3-dimethyl-5,6-dihydro-2h-pyridin-4-yl)but-3-en-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

C33H52N2O2 (508.40285719999997)


   

4-hydroxy-3,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-en-2-one

4-hydroxy-3,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-en-2-one

C34H52O3 (508.3916242)


   

1-[4-(1,3-dimethyl-5,6-dihydro-2h-pyridin-4-yl)but-3-en-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

1-[4-(1,3-dimethyl-5,6-dihydro-2h-pyridin-4-yl)but-3-en-2-yl]-9a,11a-dimethyl-7-(methylamino)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-yl acetate

C33H52N2O2 (508.40285719999997)


   

(1r,5r,7s,8r)-4-hydroxy-3,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-en-2-one

(1r,5r,7s,8r)-4-hydroxy-3,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-en-2-one

C34H52O3 (508.3916242)